SkinHealth Systems (SKIN) Operating Leases (2021 - 2026)

SkinHealth Systems (SKIN) has 6 years of Operating Leases data on file, last reported at $18.8 million in Q1 2026.

• On a quarterly basis, Operating Leases rose 94.75% year-over-year to $18.8 million in Q1 2026; TTM through Mar 2026 was $18.8 million, a 94.75% increase from a year earlier, with the FY2025 full-year figure at $9.2 million, down 42.12% from the prior year.
• Operating Leases for Q1 2026 stood at $18.8 million, up from $9.2 million in the prior quarter.
• Over the last five years, Operating Leases for SKIN reached as high as $18.8 million in Q1 2026 and fell as low as $8.5 million in Q2 2025.
• Historically, Operating Leases has averaged $11.9 million across 5 years, with a median of $12.0 million in 2022.
• Across the five-year window, Operating Leases tumbled 42.12% in 2025 and jumped 94.75% in 2026, its largest moves.
• Year by year, Operating Leases stood at $12.7 million in 2022, then fell by 26.56% to $9.3 million in 2023, then jumped by 71.26% to $16.0 million in 2024, then plunged by 42.12% to $9.2 million in 2025, then surged by 102.98% to $18.8 million in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $18.8 million in Q1 2026, $9.2 million in Q4 2025, and $10.6 million in Q3 2025.